Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Buying Virgin Galactic Stock Is a No-Brainer After Morgan Stanley’s Downgrade

What it comes down to is this: Virgin is essentially sitting at zero today. But soon enough, there will be a huge acceleration in catalysts, for both Virgin Galactic and SPCE stock.

Astra Space Stock Is an Unbelievable Long-Term Play Worth Buying on Any Dips

After Astra's upcoming launch, we could certainly get a "sell the news" reaction from Wall Street. That wouldn't be surprising. And if that does happen, buy the dip, because Astra is far more than a great near-term trade.

4 Top Stock Trades for Thursday: AMZN, SBUX, COIN, U

Amazon, Starbucks, Coinbase and Unity Software were our top stock trades. Let's look at how the charts are setting up for Thursday.

It’s Time to Take Advantage of the Smackdown in C3.ai Stock

There's a mismatch between AI's low price point and C3.ai's true value as a leader in the high-growth machine-learning niche. Buy AI stock.

Li Auto Critics Can’t Argue with the Delivery Numbers

There are multiple positive events afoot – including a potentially massive listing in Hong Kong – which could soon boost the LI stock price.

3 Stocks to Buy to Get Ahead of the Coming Metaverse Trend 

As the physical and digital worlds are merging, the metaverse is expected to transform many industries -- and make these firms stocks to buy.

Buy Carnival’s Shares as the Company’s Ships Set Sail Again

Cruise line operator Carnival is on an upswing as it returns to full operations and its future bookings return to pre-pandemic levels.

7 Best Bear Market Stocks to Buy Now in Preparation for a Downturn

These seven stocks to buy right now for a bear market are also generally strong in bull markets. Their resistance is the key element.

Is Nvidia Stock a Buy in Advance of Q2 Earnings?

Nvidia is set to report Q2 earnings on Aug. 18, and a big factor that will impact NVDA stock after will be the global chip shortage.

Don’t Be Afraid to Buy the Dip in Pinterest Stock

Pinterest shows strong revenue growth, but the market is punishing it for a drop in monthly average users. Don't be fearful of PINS stock.

7 Unstoppable Stocks to Buy to Power Up Your Portfolio

These stocks to buy can provide investors with big and consistent returns as they continue to defy expectations and soar to new heights.

DraftKings’ Q2 Earnings Show the Stock May Be Worth $80-Plus

DraftKings' Q2 sales and earnings surprise analysts, pushing up its inherent value. DKNG stock could be worth 56% more at $80.93, assuming it achieves 2025 revenue and margin targets.

7 Biotech Stocks to Buy Amid the Delta Variant’s Onslaught

You may have thought the moment of relevancy for these biotech stocks was over, but the Delta variant has changed their prospects.

3 Speculative Stocks Worth Rolling the Dice on in August

Speculative stocks are inherently risky and investors who buy them are gambling with their money. But these companies could be worth the bet.

Why Panicking Out of Uber Last Week Was Wrong

The UBER stock thesis is long term. Short-term action can get crazy but it is now consolidating to build a base in the middle of its range.

If You Can Buy Novavax Stock at Around $200, It’s a Great Long Term Bet

Good news keeps rolling in for Novavax. However, for NVAX stock to return to $300, it needs a little help from Wall Street analysts.

5 Retail Stocks to Buy Ahead of Strong Back-to-School Sales

Back-to-school retail stocks are one of the more interesting ways to play the reopening trend after more than a year of virtual learning.

Senseonics Could Go Higher, Especially if It Nabs FDA Approval

Senseonics looks interesting here, especially with possible FDA approval. SENS stock is worth about 24% more at over $4, or even $6-plus once its CGM rolls out.

Novavax Is Looking More Like a Bet Worth Taking

NVAX stock fell behind other vaccine plays early in 2021, but it might not stay behind, There's lots of evidence to suggest it could move soon